Wall Street Analysts See a 46.07% Upside in Tango Therapeutics (TNGX): Can the Stock Really Move This High?

Core Viewpoint - Tango Therapeutics, Inc. (TNGX) has seen an 18.2% increase in share price over the past four weeks, closing at $8.9, with a potential upside of 46.1% based on Wall Street analysts' mean price target of $13 [1][11]. Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $1.31, indicating variability among analysts [2]. - The lowest price target is $11.00, suggesting a 23.6% increase, while the highest target is $15.00, indicating a potential surge of 68.5% [2]. - A low standard deviation signifies strong agreement among analysts regarding the stock's price direction [9]. Earnings Estimates and Analyst Agreement - Analysts have shown increasing optimism about TNGX's earnings prospects, as evidenced by a strong consensus in revising EPS estimates higher [11]. - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 15.1%, with six estimates moving higher and no negative revisions [12]. - TNGX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors [13]. Conclusion on Price Movement - While the consensus price target may not be a reliable indicator of the stock's potential gain, the implied direction of price movement appears to be a useful guide [14].